These findings indicate that NDRG2 overexpression in 4T1 cells followed by PD-L1 downregulation could block the suppressive activity of cancer cells on T cell proliferation and rescue the proliferation activity of T cells by stimulation with antibodies. The gene discussed is NDRG2; the disease is cancer.